(Q37056584)

18 August 2017

1 reference

title

Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option? (English)

1 reference

18 August 2017

0 references

cognitive dysfunction

1 reference

inferred from title

author name string

Christopher Christodoulou

1

1 reference

18 August 2017

William S MacAllister

2

1 reference

18 August 2017

Nancy A McLinskey

3

1 reference

18 August 2017

Lauren B Krupp

4

1 reference

18 August 2017

language of work or name

1 reference

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

22

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

87-97

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200822020-00001

18 August 2017

exact match

0 references

cites work

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822020-00001

Cognitive impairment in patients with multiple sclerosis and mild physical disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822020-00001

Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822020-00001

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822020-00001

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822020-00001

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822020-00001

Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822020-00001

The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822020-00001

Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822020-00001

Amantadine treatment of fatigue associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822020-00001

Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822020-00001

Donepezil improved memory in multiple sclerosis in a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822020-00001

Evaluating storage, retention, and retrieval in disordered memory and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822020-00001

Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822020-00001

Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine

21 January 2018

1 reference

12 December 2020

Brain injury, cognitive impairment, and donepezil.

1 reference

12 December 2020

Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations

1 reference

12 December 2020

Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems

1 reference

12 December 2020

Cholinergic therapy for Down's syndrome

1 reference

12 December 2020

Donepezil in vascular dementia: combined analysis of two large-scale clinical trials

1 reference

12 December 2020

Cognitive function in patients with multiple sclerosis

1 reference

12 December 2020

Self-generation as a means of maximizing learning in multiple sclerosis: an application of the generation effect.

1 reference

12 December 2020

Donepezil for Huntington's disease

1 reference

12 December 2020

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study

1 reference

12 December 2020

1 reference

12 December 2020

Cholinergic enhancement improves performance on working memory by modulating the functional activity in distinct brain regions: a positron emission tomography regional cerebral blood flow study in healthy humans.

1 reference

12 December 2020

Cognitive impairment and decline in different MS subtypes.

1 reference

12 December 2020

Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomography.

1 reference

12 December 2020

The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up.

1 reference

12 December 2020

Neuropsychologic status in multiple sclerosis after treatment with glatiramer

1 reference

12 December 2020

Memory impairment in multiple sclerosis: a quantitative review

1 reference

12 December 2020

Executive function in multiple sclerosis. The role of frontal lobe pathology

1 reference

12 December 2020

Cholinergic modulation of speed of early information processing: the effect of donepezil on inspection time

1 reference

12 December 2020

Donepezil for dementia due to Alzheimer's disease

1 reference

12 December 2020

Mechanism of action of cholinesterase inhibitors in Alzheimer's disease.

1 reference

12 December 2020

Cognitive impairment in three subtypes of multiple sclerosis.

1 reference

12 December 2020

A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments

1 reference

12 December 2020

Cognitive therapy for multiple sclerosis: a preliminary study.

1 reference

12 December 2020

Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group.

1 reference

12 December 2020

Cognitive impairment in probable multiple sclerosis

1 reference

12 December 2020

The effects of 4-aminopyridine on cognitive function in patients with multiple sclerosis: a pilot study

1 reference

12 December 2020

Cholinergic enhancement and increased selectivity of perceptual processing during working memory.

1 reference

12 December 2020

Memory disturbance in multiple sclerosis: reconsideration of patterns of performance on the selective reminding test.

1 reference

12 December 2020

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

1 reference

12 December 2020

Cognitive enhancing effects of modafinil in healthy volunteers

1 reference

12 December 2020

Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography

1 reference

12 December 2020

The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.

1 reference

12 December 2020

Treating learning impairments improves memory performance in multiple sclerosis: a randomized clinical trial.

1 reference

12 December 2020

Memory impairment in multiple sclerosis.

1 reference

12 December 2020

Cholinesterase inhibitors for Parkinson's disease dementia

1 reference

12 December 2020

Assessing functional status: exploring the relationship between the multiple sclerosis functional composite and driving

1 reference

12 December 2020

Transient memory impairment and hallucinations associated with tolterodine use.

1 reference

12 December 2020

Evidence-based pharmacotherapy of Alzheimer's disease

1 reference

12 December 2020

Rivastigmine for dementia associated with Parkinson's disease

1 reference

12 December 2020

Detecting cognitive dysfunction in multiple sclerosis with a magnetic resonance imaging rating scale: a pilot study.

1 reference

12 December 2020

Executive functions in multiple sclerosis: an analysis of temporal ordering, semantic encoding, and planning abilities

1 reference

12 December 2020

Epidemiology of multiple sclerosis in US veterans. 4. Age at onset

1 reference

12 December 2020

Effects of neuropsychological treatment in patients with multiple sclerosis.

1 reference

12 December 2020

Physostigmine for Alzheimer's disease

1 reference

12 December 2020

Donepezil and flight simulator performance: effects on retention of complex skills

1 reference

12 December 2020

Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats

1 reference

12 December 2020

Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory

1 reference

12 December 2020

The question of disproportionate impairments in visual and auditory information processing in multiple sclerosis.

1 reference

12 December 2020

Cognitive and emotional disturbances in multiple sclerosis.

1 reference

12 December 2020

Axonal transection in the lesions of multiple sclerosis

1 reference

12 December 2020

Donepezil medicated memory improvement in traumatic brain injury during post acute rehabilitation.

1 reference

12 December 2020

Acquisition and storage deficits in multiple sclerosis.

1 reference

12 December 2020

Motor vehicle crashes and violations among drivers with multiple sclerosis

1 reference

12 December 2020

Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates

1 reference

12 December 2020

Cholinergic enhancement of frontal lobe activity in mild cognitive impairment

1 reference

12 December 2020

Frontal lobe dysfunction and memory impairment in patients with chronic progressive multiple sclerosis

1 reference

12 December 2020

The influence of cognitive impairment on driving performance in multiple sclerosis

1 reference

12 December 2020

Cognitive impairment in primary and secondary progressive multiple sclerosis.

1 reference

12 December 2020

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

1 reference

12 December 2020

Neuroscience. Boosting working memory.

1 reference

12 December 2020

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

1 reference

12 December 2020

Computer assisted retraining of attentional impairments in patients with multiple sclerosis

1 reference

12 December 2020

Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning

1 reference

12 December 2020

Psychoactive drugs and pilot performance: a comparison of nicotine, donepezil, and alcohol effects

1 reference

12 December 2020

The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice.

1 reference

12 December 2020

Benign multiple sclerosis

1 reference

12 December 2020

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

1 reference

12 December 2020

10.2165/00023210-200822020-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

18 August 2017

1027554535

0 references

1 reference